文献速递类风湿关节炎

表观遗传调控轴MIR22-TET3-MTRNR2L2抑制类风湿关节炎中成纤维样滑膜细胞介导的炎症

Epigenetic Regulatory Axis MIR22-TET3-MTRNR2L2 Represses Fibroblast-Like Synoviocyte-Mediated Inflammation in Rheumatoid Arthritis.
PubMed 文献 · Arthritis Rheumatol · 2024-03-07

该研究探讨表观遗传因子MIR22、TET3和MTRNR2L2在类风湿关节炎(RA)成纤维样滑膜细胞(FLS)中的作用。通过RA患者滑膜、关节炎小鼠模型及体外实验,发现MIR22直接抑制TET3翻译,TET3通过促进MTRNR2L2启动子5hmC生成发挥促炎作用。结论提示MIR22-TET3-MTRNR2L2通路为RA发病机制及靶点研究提供实验基础。

要点

  • MIR22在RA-FLS中直接结合TET3的3'非翻译区抑制其翻译,发挥抗炎作用。
  • TET3通过促进靶基因MTRNR2L2启动子5hmC生成,在RA-FLS中发挥促炎作用。
  • 在CAIA和CIA模型中,Mir22 angomir与Tet3 siRNA显示出对关节炎的治疗效果。

核心结论

  • MIR22-TET3-MTRNR2L2通路在RA-FLS中起关键作用,为从FLS角度进一步研究RA发病机制及相关靶点提供了实验基础。

研究设计与样本

  • 研究采用RA患者滑膜和关节炎小鼠模型,通过荧光原位杂交、qPCR、免疫组化和Western blot检测MIR22、TET3和MTRNR2L2表达。
  • 使用Mir22-/-和Tet3+/-小鼠建立胶原抗体诱导关节炎(CAIA)模型。
  • 使用Mir22 angomir和Tet3小干扰RNA(siRNA)在胶原诱导关节炎(CIA)模型中验证治疗效果。
  • 通过生物信息学、荧光素酶报告基因实验、5hmC斑点印迹、染色质免疫沉淀-qPCR和羟甲基化DNA免疫沉淀实验揭示MIR22对TET3的直接抑制及TET3对MTRNR2L2的转录激活。

主要发现

  • Mir22-/- CAIA模型和RA-FLS相关体外实验证明MIR22对炎症的抑制作用。
  • MIR22通过结合TET3的3'非翻译区直接抑制RA-FLS中TET3的翻译。
  • Tet3+/-小鼠建立的CAIA模型在体内显示关节炎症状较轻。
  • 体外实验进一步证实TET3在RA中的促炎作用。
  • CIA模型验证了Mir22 angomir和Tet3 siRNA的治疗效果;TET3通过促进其靶基因MTRNR2L2启动子中5hmC生成发挥促炎作用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The specific role of fibroblast-like synoviocytes (FLSs) in the pathogenesis of rheumatoid arthritis (RA) is still not fully elucidated. This study aimed to explore the molecular mechanisms of epigenetic pathways, including three epigenetic factors, microRNA (miRNA)-22 (MIR22), ten-eleven translocation methylcytosine dioxygenase 3 (TET3), and MT-RNR2 like 2 (MTRNR2L2), in RA-FLSs. METHODS: The expression of MIR22, TET3, and MTRNR2L2 in the synovium of patients with RA and arthritic mice were determined by fluorescence in situ hybridization, quantitative polymerase chain reaction (qPCR), immunohistochemistry, and Western blot. Mir22-/- and Tet3+/- mice were used to establish a collagen antibody-induced arthritis (CAIA) model. Mir22 angomir and Tet3 small interfering RNA (siRNA) were used to illustrate the therapeutic effects on arthritis using a collagen-induced (CIA) model. Bioinformatics, luciferase reporter assay, 5-hydroxymethylcytosine (5hmC) dot blotting, chromatin immunoprecipitation-qPCR, and hydroxymethylated DNA immunoprecipitation were conducted to show the direct repression of MIR22 on the TET3 and transcriptional activation of TET3 on MTRNR2L2. RESULTS: The Mir22-/- CAIA model and RA-FLS-related in vitro experiments demonstrated the inhibitory effect of MIR22 on inflammation. MIR22 can directly inhibit the translation of TET3 in RA-FLSs by binding to its 3' untranslated region in TET3. The Tet3+/- mice-established CAIA model showed less severe symptoms of arthritis in vivo. In vitro experiments further confirmed the proinflammatory effect of TET3 in RA. In addition, the CIA model was used to validate the therapeutic effects of Mir22 angomir and Tet3 siRNA. Finally, TET3 exerts its proinflammatory effect by promoting 5hmC production in the promoter of its target MTRNR2L2 in RA-FLSs. CONCLUSION: The key role of the MIR22-TET3-MTRNR2L2 pathway in RA-FLSs provided an experimental basis for further studies into the pathogenesis and related targets of RA from the perspective of FLSs.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Fang Y, Huang W, Zhu X, et al. Epigenetic Regulatory Axis MIR22-TET3-MTRNR2L2 Represses Fibroblast-Like Synoviocyte-Mediated Inflammation in Rheumatoid Arthritis. Arthritis Rheumatol. 2024. PMID: 38221658. doi:10.1002/art.42795

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。